Genesis MedTech and National University Health System Launch Four-Year AI Partnership to Transform Surgical Care
核心洞察
Genesis MedTech Group (搜索) and the National University Health System have established a strategic partnership to advance artificial intelligence in surgery and medical device innovation through a two-phase, four-year program.
The collaboration will co-innovate AI projects in surgery, engage NUHS clinicians for stronger alignment between product development and clinical needs, and establish the "Genesis-NUHS AI Innovation and Surgical Training Lab."
The partnership adopts a design-led approach to translate unmet clinical needs into meaningful solutions, aiming to make surgery safer, smarter and more accessible to patients worldwide.
Genesis MedTech Group (搜索) and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence in surgery and medical device innovation, marking a significant collaboration between industry and academia to transform surgical care. The partnership, announced at the World Congress of Endoscopic Surgery (搜索) (WCES), stems from a Memorandum of Understanding signed earlier this year.
Four-Year Innovation Program Structure
Under this two-phase, four-year program, the Genesis MedTech–NUHS AI Innovation Partnership adopts a design-led approach to translate unmet needs into clinically meaningful solutions. The collaboration encompasses three key components: co-innovating AI projects in surgery, engaging NUHS clinicians to enable stronger alignment between product development and real-world clinical needs, and establishing the "Genesis-NUHS AI Innovation and Surgical Training Lab."
As surgical challenges evolve, AI-driven technologies are enabling surgeons with data-driven insights to deliver safer, personalized and better outcomes for patients. At the same time, these innovations support hospitals in providing more cost-effective care.
Leadership Vision for AI-Powered Surgery
"Innovation in healthcare happens where clinicians and engineers meet," said Warren Wang, Chairman & CEO, Genesis MedTech. "Our partnership with NUHS represents our commitment to advancing AI-powered surgical innovation — built around real clinical challenges, developed hand-in-hand with hospitals."
Adjunct Professor Ngiam Kee Yuan, Head of AI Office, NUHS, emphasized the collaborative potential: "By combining NUHS's clinical and academic excellence with Genesis MedTech's global innovation platform, we aim to accelerate AI adoption to improve surgical care for patients in Singapore and internationally." Adjunct Professor Ngiam also serves as a Senior Consultant and Head of the Division of General Surgery (Endocrine & Thyroid Surgery), Department of Surgery, National University Hospital.
Global Impact and Accessibility
The Genesis–NUHS AI Innovation Partnership represents a long-term commitment to advancing healthcare through AI and close clinician-industry collaboration, making surgery safer, smarter and more accessible to patients worldwide. The partnership positions both organizations at the forefront of surgical innovation, combining clinical expertise with technological advancement to address real-world medical challenges.
Genesis MedTech Group (搜索), headquartered in Singapore, operates as a global medical device company dedicated to making treatments safer, less invasive and more accessible at scale. The company maintains integrated capabilities from R&D and manufacturing to commercialization, delivering high-quality medical devices across surgical, cardiology, and vascular interventional specialties.
NUHS operates as a Regional Health System that integrates patient care, health science education and biomedical research under a common governance structure. The system includes multiple hospitals, national specialty centers, and health sciences schools, creating synergies for health advancement across Singapore's western region.